Newly Approved Drug Therapies (569): Zofran ODT, GlaxoWellcome

Description of Medical Areas

About the FDA Approved Listings

Drugs Approved by the FDA

Drug Name: Zofran ODT

The following information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company: GlaxoWellcome
Approval Status: Approved January 1999
Treatment for: Oncology

General Information

Zofran ODT (odansetron) Orally Disintegrating Tablets have been approved for prevention of chemotherapy and radiation-induced nausea and vomiting, and prevention of postoperative nausea and vomiting.

Back to Drug Listing

Drug listing last updated on February 19, 2008

PAC> (counter)

Patient Resources: [ Trial Listing ] [ Notification Services ] [ Drug Directories ]
[ About Clinical Research ] [ Patient Resources ] [ Patient Bookstore ]
Professional Resources: [ Research Center Profiles ] [ Industry Provider Profiles ] [ Jobs in Clinical Research ]
[ Industry News ] [ Professional Resources ] [ Professional Bookstore ]
General: [ Search ] [ Site Map ] [ Your Privacy ] [ CW World ] [ Home ]